Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.92 USD | +1.05% | -11.93% | -33.79% |
May. 15 | Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents | CI |
May. 14 | William Blair Upgrades Neuronetics to Outperform From Market Perform | MT |
Financials (USD)
Sales 2024 * | 79.14M | Sales 2025 * | 89.83M | Capitalization | 57.6M |
---|---|---|---|---|---|
Net income 2024 * | -27M | Net income 2025 * | -20M | EV / Sales 2024 * | 0.73 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.64 x |
P/E ratio 2024 * |
-2.08
x | P/E ratio 2025 * |
-2.97
x | Employees | 202 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.69% |
Latest transcript on Neuronetics, Inc.
1 day | +1.05% | ||
1 week | -11.93% | ||
1 month | -43.03% | ||
3 months | -36.00% | ||
6 months | +5.49% | ||
Current year | -33.79% |
Managers | Title | Age | Since |
---|---|---|---|
Keith Sullivan
CEO | Chief Executive Officer | 65 | 20-07-13 |
Stephen Furlong
DFI | Director of Finance/CFO | 60 | - |
Cory Anderson
CTO | Chief Tech/Sci/R&D Officer | - | 21-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Cascella
CHM | Chairman | 69 | 21-03-31 |
Sheryl Conley
BRD | Director/Board Member | 63 | 19-09-30 |
Glenn Muir
BRD | Director/Board Member | 65 | 17-06-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 1.92 | +1.05% | 130,596 |
24-05-30 | 1.9 | -6.86% | 672,041 |
24-05-29 | 2.04 | -1.92% | 95,720 |
24-05-28 | 2.08 | -4.59% | 67,425 |
24-05-24 | 2.18 | -5.22% | 138,511 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.79% | 57M | |
+7.01% | 215B | |
+11.01% | 187B | |
+19.20% | 143B | |
+30.79% | 110B | |
+1.48% | 64.68B | |
+13.95% | 52.96B | |
-0.16% | 49.84B | |
-6.20% | 38.32B | |
+0.91% | 35.86B |
- Stock Market
- Equities
- STIM Stock